Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Myeloid 5Lymphoid 2Plasma cell 1Classical hematology 1

Conditions

Multiple Myeloma 20Neoplasms, Plasma Cell 9Pain 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Breast Neoplasms 2cyclopia sequence 1Weight Loss 1Thrombocytopenia 1Splenomegaly 1Smoldering Multiple Myeloma 1Neoplasms 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Lymphocytosis 1Lymphadenopathy 1Lung Neoplasms 1Leukemia 1Immunoglobulin Light-chain Amyloidosis 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Fever 1Fatigue 1Coronavirus Infections 1Colorectal Neoplasms 1Behavioral Symptoms 1Anosmia 1Anemia 1Amyloidosis 1

Interventions

Cyclophosphamide 89fludarabine phosphate 77Mycophenolic Acid 53Tacrolimus 52Peripheral Blood Stem Cell Transplantation 50Busulfan 44Whole-Body Irradiation 43Antilymphocyte Serum 41fludarabine 37Cyclosporine 36Filgrastim 32Melphalan 27Methotrexate 26Radiotherapy 23Cord Blood Stem Cell Transplantation 19Methylprednisolone 18Granulocyte Colony-Stimulating Factor 16Sirolimus 14Etoposide 13Alemtuzumab 12thymoglobulin 11sargramostim 11Stem Cell Transplantation 11Rituximab 11Thiotepa 9Azacitidine 8Cytarabine 7Psychiatric Rehabilitation 6Prednisone 6Flow Cytometry 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × Surveys and Questionnaires × Plasma cell × Clear all
NCT01875237 2019-07-16

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

M.D. Anderson Cancer Center

Phase 1/2 Terminated
3 enrolled 15 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡